The Centers for Medicare & Medicaid Services yesterday released a request for applications to participate in the Part D Payment Modernization Model in calendar year 2022.

The five-year model, which began this month, will test new incentives for Medicare prescription drug plans, patients and providers to choose drugs with lower list prices. For CY 2022, CMS said the model will test new flexibilities to better align Part D formularies with other pharmacy benefit designs in the commercial and individual markets, and remove the model’s downside risk.

Interested Part D sponsors should submit a non-binding notice of intent to apply by March 1 and an application by April 16, 2021.

Related News Articles

Headline
The Department of Health and Human Services Jan. 17 announced 15 Medicare Part D drugs selected for the latest round of price negotiations. Negotiations will…
Headline
The Medicare Payment Advisory Commission today voted to recommend that Congress update Medicare payment rates for hospital inpatient and outpatient services by…
Headline
The Centers for Medicare & Medicaid Services Jan. 10 proposed a 4.3% payment increase to Medicare Advantage plans for calendar year 2026, amounting to…
Headline
Prices for the top 25 brand-name Medicare Part D drugs have increased by an average of 98% since entering the market, according to a report released Jan. 9 by…
Headline
The AHA Dec. 17 released its Health Care Plan Accountability Update, covering the latest developments in Medicare Advantage, legislation and regulation of…
Headline
The AHA today participated in a panel discussion during a conference hosted by The Capitol Forum on the impact of insurer vertical integration. Molly Smith,…